Reading this on a mobile device? Try our optimized mobile version here:

December 4, 2012
Sign upForwardArchiveAdvertise
Right Care. Right Now.

  Critical Care Update 
  • Hospital room cleaning does not get all bacteria, study says
    Post-discharge cleaning still left 25% of hospital ICU rooms and 5.5% of sites within a room contaminated with drug-resistant bacteria, researchers reported in the American Journal of Infection Control. Researchers said the use of hydrogen peroxide vapor and ultraviolet light cleaning may be more effective but it increases turn-around time for the room. MedPage Today (free registration) (12/3) LinkedInFacebookTwitterEmail this Story
  • Other News
Pupillometry in Critical Care
The NeurOptics® NPi™-100 Pupillometer is a noninvasive, simple to use, handheld device which removes subjectivity in the pupillary evaluation. Now even the smallest changes in pupillary function not discernable to the naked eye are detectable by clinicians and can be measured, quantified, and trended. Click here to learn more or to arrange a no obligation demonstration or trial. Please visit us at the upcoming SCCM Congress in Puerto Rico in January (Booth #914)!
  Medicine in the News 
  • Hospital trend of employing physicians causes controversy
    The hospital trend of buying up physician practices has hit a boiling point in Boise, Idaho, as the area's largest health system is accused of having too much market control, affecting patient care and procedure costs. While some policy experts say moving away from independent practices makes health care less fragmented and expensive, some physicians say hospitals are pressuring them to admit more patients to meet financial targets. The New York Times (tiered subscription model) (11/30) LinkedInFacebookTwitterEmail this Story
  • Theravance's Vibativ gains partial support from FDA panel
    An FDA advisory panel endorsed the approval of Theravance's once-daily antibiotic Vibativ to treat patients with hospital-acquired pneumonia when other alternatives are not suitable. But the drug failed to win the advisory committee's approval recommendation as a first-line therapy for the condition, also known as nosocomial pneumonia. Trial data failed to offer "substantial evidence" of Vibativ's safety and efficacy against hospital-acquired pneumonia, the panel said. American City Business Journals/San Francisco/BiotechSF blog (11/30) LinkedInFacebookTwitterEmail this Story
  Trends and Technology 
  • Other News
It is astonishing what force, purity and wisdom it requires for a human being to keep clear of falsehoods."
--Margaret Fuller,
American journalist and women's rights activist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Sales Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent Critical Care SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information